Favipiravir

Overview

Favipiravir (T-705) is a potent viral RNA polymerase inhibitor, it is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5′-triphosphate (RTP). Favipiravir-RTP inhibits the influenza viral RNA-dependent RNA polymerase ( RdRP ) activity with an IC 50 of 341 nM.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Influenza Virus | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-14768
• CAS No.: 259793-96-9
• Molecular Formula: C5H4FN3O2
• Molecular Weight: 157.10
• Purity: 99.98%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (15.91 mM); Clear solution
• Availability: In-stock

Source

Original product source